CIK 0001701108 · Non-accelerated filer<br>Smaller reporting company
Spero Therapeutics, Inc.
Sign in to watch- Ticker
- SPRO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 857-242-1600
- Business address
- 675 MASSACHUSETTS AVENUE, 14TH FLOOR, CAMBRIDGE, MA, 02139
- Former names
- Spero Therapeutics, LLC
- 3 Insider Initial Statement of Ownership
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 8-K Event Regulation FD disclosure
- 8-K Event Executive or director change
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 424B5 Offering Prospectus
- 8-K Event Material agreement
- 8-K Event Shareholder vote results
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- DEF 14A Proxy Proxy Statement
- 8-K Event Executive or director change
Page 20 of 27 · 521 filings